Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
World Neurosurg. 2024 Jun;186:e114-e124. doi: 10.1016/j.wneu.2024.03.069. Epub 2024 Mar 19.
Petroclival meningiomas invade Meckel's cave through the porus trigeminus, leading to secondary trigeminal neuralgia. Microsurgery and stereotactic radiosurgery (SRS) are the typical treatment options. This study investigated symptom control, outcomes, and surgical strategies for PC meningioma-induced TN.
We retrospectively analyzed 28 TN patients with PC meningiomas who underwent microsurgical nerve decompression between January 2021 and February 2023. In all patients undergoing a transpetrosal approach, the porus trigeminus was opened to enable the removal of the entire tumor within Meckel's cave. Clinical outcomes were assessed using the Barrow Neurologic Institute (BNI) pain intensity scale. Risk factors for poor TN outcomes and poor facial numbness were analyzed.
Among 28 patients, 21 (75%) underwent the transpetrosal approach, 5 (17.9%) underwent the retrosigmoid approach, and 2 (7.1%) underwent the Dolenc approach. Following microsurgery, 23 patients (82.1%) experienced TN relief without further medication (BNI I or II). TN recurrence occurred in 2 patients (7.1%), and 3 patients (10.7%) did not achieve TN relief. Cavernous sinus invasion was significantly correlated with poor TN outcomes (P = 0.047). A history of previous SRS (P = 0.011) and upper clivus type tumor (P = 0.018) were significantly associated with poor facial numbness.
Microsurgical nerve decompression is effective in improving BNI scores in patients with TN associated with PC meningiomas. Considering the results of our study, the opening of the porus trigeminus can be considered as a suggested procedure in the treatment of PC meningiomas, especially in cases accompanied by TN.
岩斜脑膜瘤通过三叉神经孔侵入 Meckel 腔,导致继发性三叉神经痛。显微手术和立体定向放射外科(SRS)是典型的治疗选择。本研究探讨了岩斜脑膜瘤引起的 TN 的症状控制、结果和手术策略。
我们回顾性分析了 2021 年 1 月至 2023 年 2 月期间接受显微神经减压手术的 28 例 PC 脑膜瘤伴 TN 患者。所有接受经岩骨入路的患者,三叉神经孔均被打开,以便在 Meckel 腔内完全切除肿瘤。采用 Barrow 神经病学研究所(BNI)疼痛强度量表评估临床结果。分析了 TN 预后不良和面部麻木不良的危险因素。
28 例患者中,21 例(75%)采用经岩骨入路,5 例(17.9%)采用乙状窦后入路,2 例(7.1%)采用 Dolenc 入路。显微手术后,23 例(82.1%)患者 TN 缓解,无需进一步药物治疗(BNI I 或 II 级)。2 例(7.1%)患者出现 TN 复发,3 例(10.7%)患者 TN 缓解不明显。海绵窦侵犯与 TN 预后不良显著相关(P=0.047)。有 SRS 治疗史(P=0.011)和上斜坡肿瘤(P=0.018)与面部麻木不良显著相关。
显微神经减压术可有效改善 TN 患者的 BNI 评分。考虑到我们的研究结果,三叉神经孔的开放可以被认为是岩斜脑膜瘤治疗的一种推荐方法,尤其是在伴有 TN 的情况下。